Idiopathic Thrombocytopenic Purpura (ITP) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate® (romiplostim) In Pediatric Patients With Chronic ... - PR Newswire (press release)



Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate® (romiplostim) In Pediatric Patients With Chronic ... 
PR Newswire (press release)
... Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current indication for Nplate® (romiplostim) to include the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP ...

and more » 


Castle Douglas woman Laura Thomson raises more than £1000 for charity despite dislocated shoulder - Scottish Daily Record



Scottish Daily Record
 
Castle Douglas woman Laura Thomson raises more than £1000 for charity despite dislocated shoulder 
Scottish Daily Record
A Castle Douglas woman ran through the pain of a dislocated shoulder to raise money for a cause close to her heart. Twenty-six-year-old Laura Thomson took on the Great Scottish Run in Glasgow last month to raise money for Immune Thrombocytopenic ...

 


Global Intravenous Immunoglobulin (IGM, IGG, IGE, Immunoglobulin D (IGD) and IGA) Market, 2025 - PR Newswire (press release)



Global Intravenous Immunoglobulin (IGM, IGG, IGE, Immunoglobulin D (IGD) and IGA) Market, 2025 
PR Newswire (press release)
... immunodeficiency diseases, myasthenia gravis, hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), inflammatory myopathies, kawasaki disease, idiopathic thrombocytopenic purpura (ITP), guillain-barre syndrome (GBS), ...

and more » 


Amgen Gets Positive CHMP Opinion to Expand Nplate's Label - Nasdaq



Amgen Gets Positive CHMP Opinion to Expand Nplate's Label 
Nasdaq
Nplate is presently marketed for the treatment of chronic immune thrombocytopenic purpura (ITP) - an autoimmune disease characterized by low platelet count - in adults. Amgen is looking to get Nplate approved for use in pediatric patients (one year of ...

and more » 


Edible weeds the focus for Whanganui workshop - New Zealand Herald



Edible weeds the focus for Whanganui workshop 
New Zealand Herald
Ms Sich had years of ill-health, including being diagnosed with the auto-immune disease Idiopathic Thrombocytopenic Purpura (ITP) or low platelets, and had a brain bleed which required six months in hospital. She attributes her current wellbeing to a ...

and more » 


Positive opinion to extend use of romiplostim in paediatric patients - Hospital Healthcare Europe



Positive opinion to extend use of romiplostim in paediatric patients 
Hospital Healthcare Europe
... current indication for Nplate® (romiplostim) to include the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) for patients one year of age and older who are refractory to other treatments (for example,corticosteroids ...

 


4 Infusions That Can Help Relieve Chronic Pain - Pain News Network



Pain News Network
 
4 Infusions That Can Help Relieve Chronic Pain 
Pain News Network
If you have the cash, the FDA has approved IVIg for graft disease and idiopathic thrombocytopenic purpura (ITP). It is also used to treat patients with Kawasaki disease, Guillain-Barre syndrome, and polymyositis/dermatomyositis. I know a number of ...

 


What Does It Mean If You Have Low Platelets During Pregnancy? An Expert Explains - Romper



Romper
 
What Does It Mean If You Have Low Platelets During Pregnancy? An Expert Explains 
Romper
... three most common reasons for low platelets in pregnancy are gestational thrombocytopenia, hypertensive disorders such as preeclampsia leading to low platelet count, and a preexisting autoimmune cause called immune thrombocytopenic purpura (ITP).?.

 


HC Wainwright Assumes Rigel Pharmaceuticals (RIGL) at Buy - StreetInsider.com



BZ Weekly
 
HC Wainwright Assumes Rigel Pharmaceuticals (RIGL) at Buy 
StreetInsider.com
Analyst Joseph Pantginis notes their primary investment thesis on the company revolves around fostamatinib and the upcoming PDUFA date in April 2018 where we project FDA approval for the treatment of immune thrombocytopenic purpura (ITP). While they ...
The Rigel Pharmaceuticals Inc. (RIGL) Position Maintained by California Public Employees Retirement System BangaloreWeekly
7 Stocks of the Month: December Edition Zacks.com
Rigel Pharmaceuticals, Inc. - RIGL - Stock Price Today - Zacks Zacks Investment Research

all 56 news articles » 


JP Hilsabeck -- 6 things to know about the 'Survivor: Heroes vs. Healers vs. Hustlers' castaway - Reality TV World



Reality TV World
 
JP Hilsabeck -- 6 things to know about the 'Survivor: Heroes vs. Healers vs. Hustlers' castaway 
Reality TV World
JP wants to win the million dollars on Survivor in order to donate money to his sister's foundation to help find a cure for idiopathic thrombocytopenic purpura, better known as ITP, which is an autoimmune disorder having to do with low levels of platelets.

and more »